GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ASN-008 | ASN008
Compound class:
Synthetic organic
Comment: Permanently charged sodium channel blocker with analgesic potential. This entry shows the compound without the associated bromide ion [1].
The chemical structure is identical to that for the parent compound of the INN olisutrigine bromide (proposed list 132, Feb. 2025). |
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| In human clinical trials as a topical gel for the treatment of pruritus (itch) associated with atopic dermatitis. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT03798561 | Study to Evaluate ASN008 Topical Gel (TG) | Phase 1 Interventional | Asana BioSciences | ||